Task: Answer the multiple-choice question.
Question: Which compound exhibits a -27.385% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) Cc1cc(C)c([N+](=O)[O-])cc1NCC(=O)N1CCN(c2ccccc2)CC1
(b) Cc1cc(=O)c2n(Cc3ccc(Cl)cc3)nc[n+]2[nH]1.[Cl-]
(c) Br.CCCN1CCc2cc(O)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.O
(d) CCC(=O)c1ccc(OCCSc2ncccn2)cc1
Answer: d. CCC(=O)c1ccc(OCCSc2ncccn2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)c1ccc(OCCSc2ncccn2)cc1
CCC(=O)c1ccc(OCCSc2ncccn2)cc1
1-[4-(2-pyrimidin-2-ylsulfanylethoxy)phenyl]propan-1-one